Bio-Rad Laboratories, Inc. (BIO) NYSE

284.31

-1.35(-0.47%)

Updated at August 18 03:07PM

Currency In USD

Valuation

Market Cap9.27B
Enterprise Value10.16B
P/E Ratio24.25
PEG Ratio0.21
Price/Sales Ratio3.01
Price/Book Ratio1.09
Enterprise/Revenue3.42
Enterprise/EBITDA12.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.09

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue2.57B
Revenue/Share93.81
Gross Profit1.38B
EBITDA-2.14B
Net Income-1.84B
Diluted EPS-65.36

Balance Sheet

Total Cash1.37B
Total Cash/Share50.46
Total Debt1.41B
Total Debt/Equity0.2
Current Ratio5.12
Book Value Per Share261.83

Price History

52-Week Change-12.88
52-Week High387.99
52-Week Low211.43
Moving Average 50 Days250.31
Moving Average 200 Days282.83

Statistics

Average Volume348,716
Shares Outstanding27.06M
% Held by Institutions69.1

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.15
Last Split Factor2:1
Last Split DateMarch 08, 2002